Table 5.
Percent of abnormal blood glucose values prior to pharmacotherapy initiation | Adjusted linear regression coefficient (95% CI) | p-value |
---|---|---|
Race | ||
Non-Hispanic White | Ref | |
Non-Hispanic Black | 18.71 (11.63 – 25.79) | <0.001 |
Hispanic | 11.64 (3.26 – 20.03) | 0.007 |
Other | 8.53 (0.92 – 16.14) | 0.028 |
Maternal age | −0.14 (−0.64 – 0.35) | 0.568 |
Body mass index in early pregnancy(kg/m2) | 0.47 (0.18 – 0.76) | 0.001 |
Marital Status | ||
Single | Ref | |
Married | −1.31 (−7.30 – 4.68) | 0.667 |
Divorced | 7.27 (−6.97 – 21.51) | 0.316 |
Insurance Status | ||
Private | Ref | |
Public | 7.26 (1.00 – 13.53) | 0.023 |
None | −4.82 (−12.95 – 3.30) | 0.244 |
Preexisting hypertension | ||
No | Ref | |
Yes | −2.74 (−15.50 – 10.02) | 0.673 |
Gestational age at GDM diagnosis (wks) | 0.19 (−0.48 – 0.86) | 0.577 |
Bold indicates significant p-value